CARDIOVASCULAR DRUGS MARKET ANALYSIS

Cardiovascular Drugs Market, by Drug Class (Anti-Hyperlipidemics, Anti-Hypertensive, Anti-Coagulants, Anti-Arrhythmic, Anti-Fibrinolytic, and Others {Cardiac Glycosides, Anti-Ischemic Drugs, and Antianginal Drugs}), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Nov 2024
Code : CMI1167
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Some of the major players operating in the global cardiovascular drugs market are Pfizer Inc., Bayer AG., Novartis AG., Merck and Co. Inc., AstraZeneca Plc, Bristol Myers Squibb Company, Abbott Laboratories, Sun Pharma Industries, Gilead Sciences Inc., Otsuka Holdings Co., Ltd. Takeda Pharmaceutical Company Ltd, Eli Lilly and Company, and Johnson & Johnson.